Patent · US Active

Process for synthesis of quinazoline compounds

US12071422B2 · kind B2 · utility

0Cited by

0References

48Claims

0Family size

Assignees

Genentech, Inc. · US
Hoffmann-La Roche Inc. · US

Inventors

Rene LEBL · Graz, AT
Ngiap-Kie Lim · South San Francisco, US
Roland Meier · Ueken, CH
Ugo Jonathan Orcel · Basel, CH
Joerg Sedelmeier · Basel, CH
Jeff Shen · Foster City, US
Lauren Elizabeth SIROIS · San Francisco, US
Jacob C. Timmerman · San Mateo, US
Etienne Trachsel · Basel, CH
Nicholas Andrew White · San Francisco, US
Jie Xu · Foster City, US
Haiming Zhang · Pennington, US
Stephan Bachmann · Allschwil, CH
Thomas Michael BASS · Fremont, US
Raphael BIGLER · Basel, CH
Johannes Adrian BURKHARD · Millbrae, US
Kyle Bradley Pascual Clagg · San Francisco, US
Francis Gosselin · South San Francisco, US
Chong Han · Foster City, US
Dainis Kaldre · Lörrach, DE
Sean M. Kelly · Williamsville, US
Sebastian Herold · Bad Säckingen, DE
Christian LEITNER · Eiken, CH

Key dates

Filing date	Feb 3, 2023
Grant date	Aug 27, 2024
Priority date	—
Expiry date	Feb 3, 2043

Classification

Technology area (CPC B)Performing Operations; Transporting
CPC primaryB01J23/755
WIPO fieldChemical engineering
WIPO sectorChemistry

Abstract

Provided herein are methods to synthesize compounds useful in the treatment of cancer where such compounds comprise a quinazolinyl core moiety and at least one stereoisomeric or atropisomeric moiety.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.